SCHEMBL808221

SCHEMBL808221

C=C(/N=C(N)\N=C(/N)c1noc(-c2ccc(C)s2)n1)N(C)c1ccccc1

nearest known ligand 0.32

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.32
MMP2 P08253 1/20 0.30
MMP9 P14780 1/20 0.30
MMP8 P22894 1/20 0.30
MMP12 P39900 1/20 0.30
MMP13 P45452 1/20 0.30
POLB P06746 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL808333 0.81 NPC1 (0.37) SIGMAR1POLB
SCHEMBL807994 0.80 SIGMAR1 (0.31) SIGMAR1
SCHEMBL808229 0.80 SIGMAR1 (0.32) SIGMAR1
SCHEMBL807906 0.79 SMN1; SMN2 (0.40)
SCHEMBL807993 0.79 GRM5 (0.39) SIGMAR1
SCHEMBL808224 0.79 SIGMAR1 (0.32) SIGMAR1
SCHEMBL10287187 0.79 ALDH1A1 (0.45)
SCHEMBL808235 0.79 HDAC6 (0.34) SIGMAR1
SCHEMBL807976 0.78 SIGMAR1 (0.31) SIGMAR1
SCHEMBL808211 0.77 RPS6KA2 (0.33) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012035023-A1 TRIAZINE-OXADIAZOLES NOVARTIS AG (CH) 2012-03-22 WO disclosed